MobiHealth News September 22, 2021
Laura Lovett

The Wall Street Journal reports that the work on the feature could be born out of collaborations with UCLA and Biogen.

Apple is looking to use digital biomarkers to help detect depression and early-stage cognitive decline, according to a new report out of The Wall Street Journal.

The end goal, according to the Journal, is to create a new Apple feature that would tell users if there was a potential mental illness. Data collected regarding a users’ mobility, physical activity, sleep pattern could be included in the algorithm.

The report notes that the new effort could be tied to collaborations that the Silicon Valley titan already has established with UCLA researchers and pharma company Biogen.

At the beginning...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mental Health, mHealth, Provider, Technology
AHRQ guide provides ways to support equity through digital health care technology
Clinicians, staff highlight strategies to enhance virtual diabetes care
Scopio Labs gains De Novo clearance for AI bone marrow analysis software and more FDA clearances
Optum layoffs: naviHealth CEO out; Virtual care business shuttered
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired

Share This Article